Skip to main content
Log in

Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons?

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The dopamine (DA)-receptor mediated changes in striatal acetylcholine (ACh) levels have been studied to determine if this effect involves a D1-(adenylate cyclase dependent) or D2-(not linked to an adenylate cyclase) type of DA-receptor. Various DA-agonists (apomorphine, N-diphenethylamine derivatives) increased striatal ACh levels in both intact and 6-OHDA lesioned rats whereas only apomorphine stimulated the adenylate cyclase activity of striatal homogenates. The N-diphenethylamine compounds (RU 24213, RU 24926 and RU 26933) were without effect either on basal or DA-stimulated activities of this enzyme. In contrast, D-LSD (which acts as a partial agonist of the striatal DA-sensitive adenylate cyclase) did not modify the striatal ACh content. More interestingly, an intrastriatal injection of cholera toxin greatly stimulated striatal adenylate cyclase without altering ACh concentrations. Both haloperidol and methergoline antagonized the DA stimulation of adenylate cyclase, but only haloperidol decreased striatal ACh levels. These results indicate that the DA receptor involved in regulating the activity of striatal cholinergic neurons is of the D2-type.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bartholini, G., Stadler, H., Lloyd, K. G.: The effect of striatal neurotransmitters. In: Neuropsychopharmacology, Proc. IX, Congress CINP (J. R. Boissier, H. Hippius and D. Pichot, eds.), pp. 487–492. Amsterdam: Excerpta Medica 1975

    Google Scholar 

  • Bockaert, J., Premont, J., Glowinski, J., Thierry, A. M., Tassin, J. P.: Topographical distribution of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase-interaction of d-LSD with dopaminergic receptors. Brain Res. 107, 303–315 (1976)

    Google Scholar 

  • Boissier, J. R., Dumont, C., Laurent, J., Oberlander, C.: Profil psychopharmacologique d'un nouvel agoniste dopaminergique: le Ru 2413. Psychopharmacology (in press 1979)

  • Clement-Cormier, C. Y., Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc. Natl. Acad. Sci. USA 71, 1113–1117 (1974)

    Google Scholar 

  • Consolo, S., Ladinsky, H., Garattini, S.: Effect of several dopaminergic drugs and trihexylphenidyl on cholinergic parameters in the rat striatum. J. Pharm. Pharmacol. 26, 275–277 (1974)

    Google Scholar 

  • Consolo, S., Ladinsky, H., Bianchi, S.: Decrease in rat striatal acetylcholine levels by some direct and indirect acting dopaminergic antagonists. Eur. J. Pharmacol. 33, 345–351 (1975)

    Google Scholar 

  • Coyle, J. T., Schwarcz, R.: Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 263, 244–246 (1976)

    Google Scholar 

  • Di Paolo, T., Beaulieu, M., Labrie, F., Nedelec, L., Raynaud, J. P., Boissier, J. R.: Activity of a new series of dopaminergic agonists on the pituitary dopamine receptor. Eur. J. Pharmacol. (in press 1979)

  • Domino, E. F., Wilson, A. E.: Psychotropic drugs influences on brain acetyl choline utilization. Psychopharmacology (Berl.) 25, 291–298 (1972)

    Google Scholar 

  • Fuxe, K., Fredholm, B. B., Agnati, L. F., Corrodi, H.: Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors. Brain Res. 146, 295–311 (1978)

    Google Scholar 

  • Garau, L., Govoni, S., Stefanini, E., Trabucchi, M., Spano, P. F.: Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci. 23, 1745–1750 (1978)

    Google Scholar 

  • Guyenet, P. G., Agid, Y., Javoy, F., Beaujouan, J. C., Rossier, J., Glowinski, J.: Effects of dopaminergic receptor agonists and antagonists on the activity of the neostriatal cholinergic system. Brain Res. 84, 227–244 (1975)

    Google Scholar 

  • Guyenet, P. G., Javoy, F., Euvrard, C., Glowinski, J.: The effect of drugs on choline and acetylcholine content in the rat striatum following two methods of sacrifice. Neuropharmacology 16, 385–390 (1977)

    Google Scholar 

  • Kebabian, J. W., Calne, D. B.: Multiple receptors for dopamine. Nature 277, 93–96 (1979)

    Google Scholar 

  • Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine sensitive adenylate cyclase in caudate nucleus of rat brain and its similarity of the “dopamine receptor”. Proc. Natl. Acad. Sci. USA 69, 2145–2149 (1972)

    Google Scholar 

  • Kebabian, J. W., Calne, D. B., Kebabian, P. R.: Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro. Com. Psychopharmacol. 1, 311–318 (1977)

    Google Scholar 

  • König, J. F., Klippel, R. A.: The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore: Williams and Wilkins 1963

    Google Scholar 

  • Lloyd, K. G.: Neurotransmitter interactions related to central dopamine neurons. Essays in neurochemistry and neuropharmacology, Vol. 3, (M. B. H. Youdim, W. Lovenberg, D. F. Sharman, J. R. Lagnado, eds.), pp. 129–208. New York: John Wiley 1978

    Google Scholar 

  • McGeer, P. L., Grewaal, D. S., McGeer, E. G.: Influence of noncholinergic drugs on rat striatal ACh levels. Brain Res. 80, 211–217 (1974)

    Google Scholar 

  • Miller, J. R., Horn, A. S., Iversen, L. L.: The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′,5′-monophosphate production in rat neostriatum and limbic forebrain. Mol. Pharmacol. 10, 759–766 (1974)

    Google Scholar 

  • Miller, R. J., Kelly, P. H.: Dopamine-like effects of cholera toxin in the central nervous system. Nature 255, 163–166 (1975)

    Google Scholar 

  • Nedelec, L., Dumont, C., Oberlander, C., Frechet, D., Laurent, J., Boissier, J. R.: Synthèse et étude de l'activité dopaminergique de derivés de la diphenéthyl amine. Eur. J. Med. Chem. 13, 553–563 (1978)

    Google Scholar 

  • Pepeu, G.: The release of ACh from the brain: an approach to the study of the central cholinergic mechanisms. In: Progress in neurobiology, Vol. 2, part 3 (G. A. Korkut, J. W. Phillis, eds.), pp. 257–288. Oxford: Pergamon Press 1973

    Google Scholar 

  • Scatton, B., Bischoff, S., Dedek, J., Korf, J.: Regional effects of neuroleptics on dopamine metabolism and dopamine sensitive adenylate cyclase activity. Eur. J. Pharmacol. 44, 287–292 (1977)

    Google Scholar 

  • Schwarcz, R., Fuxe, K., Agnati, L. F., Gustafsson, J.: Effects of bromocryptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase. Life Sci. 23, 465–470 (1978)

    Google Scholar 

  • Sethy, V. H., von Woert, M. H.: Regulation of striatal ACh concentration by dopamine receptors. Nature 251, 528–530 (1974)

    Google Scholar 

  • Spano, P. F., Trabucchi, M.: Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens. Gerontology 24, (suppl. 1) 106–114 (1978)

    Google Scholar 

  • Spano, P. F., Goroni, S., Trabucchi, M.: Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv. Biochem. Psychopharmacol. 19, 155–165 (1978)

    Google Scholar 

  • Stadler, H., Lloyd, K. G., Gadea-Ciria, M., Bartholini, G.: Enhanced striatal release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)

    Google Scholar 

  • Trabucchi, M., Cheney, D. L., Racagni, G., Costa, E.: Involvement of brain cholinergic mechanisms in the action of chlorpromazine. Nature 249, 664–666 (1974)

    Google Scholar 

  • Trabucchi, M., Longoni, R., Fresia, P., Spano, P. F.: Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain. Life Sci. 17, 1551–1556 (1975a)

    Google Scholar 

  • Trabucchi, M., Cheney, D. L., Racagni, G., Costa, E.: In vivo inhibition of striatal ACh turnover by 1-DOPA, apomorphine and (+)-amphetamine. Brain Res. 85, 130–134 (1975b)

    Google Scholar 

  • Thal, L. J., Makman, M. H., Ahn, H. S., Mishra, R. K., Horowitz, S. G., Dvorkin, B., Katzman, R.: 3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions. Life Sci. 23, 629–634 (1978)

    Google Scholar 

  • Ungerstedt, U., Ljungberg, T., Scheltz, W.: Dopamine receptor mechanisms behavioral and electrophysiological studies. In: Dopamine (T. G. Roberts, K. J. Woodruff, L. L. Iversen, eds.), pp. 311–321. New York: Raven Press 1978

    Google Scholar 

  • Van Heynigan, W. E.: Gangliosides as membrane receptors for tetanus toxin cholera toxin and serotonin. Nature 249, 415–419 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Euvrard, C., Premont, J., Oberlander, C. et al. Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons?. Naunyn-Schmiedeberg's Arch. Pharmacol. 309, 241–245 (1979). https://doi.org/10.1007/BF00504756

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00504756

Key words

Navigation